Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 5, 2024 | GPN Vaccines | $12.0M Other Equity | Forepont Capital Partners, Kern Capital | — |
| Jun 30, 2021 | Apton Biosystems | $24.0M Series A | Jay Kern | Casdin Capital, Khosla Ventures |
| Feb 1, 2021 | Personal Genome Diagnostics | $100.0M Series C | Kevin Raidy | Northpond Ventures, Questa Capital, Vensana Capital, Catalio Capital Management, Innovatus Capital Partners, New Enterprise Associates, PFM Health Sciences, Rock Springs Capital, Sands Capital, Windham Venture Partners |
| May 21, 2019 | Concentric Analgesics | $76.0M Series B | Larry Feinberg | Cowen Healthcare Investments, Venrock |
| Oct 1, 2015 | Quri | $17.0M Series C | Kern Capital | Benchmark, Matrix, Glenn Solomon, Propeller VC, Redpoint Ventures, Catamount Ventures, Matrix Partners, Simon Equity Partners |
| Feb 15, 2013 | Cohera Medical | $17.0M Series D | Jay Kern | — |
| Sep 6, 2012 | UserTesting | $3.0M Other Equity | Kern Capital | — |
| Dec 19, 2011 | Cohera Medical | $25.0M Series C | — | — |